XML 71 R65.htm IDEA: XBRL DOCUMENT v3.25.3
Stockholders' Equity (Additional Information) (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 4 Months Ended 9 Months Ended
Apr. 30, 2024
Sep. 30, 2025
Jun. 30, 2024
Apr. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Oct. 31, 2022
Warrants exercised   590,703     590,703    
Exercise price of warrants   $ 18.11     $ 18.11    
Proceeds from exercise of warrants   $ 10,700     $ 10,698 $ 0  
Outstanding warrants   0     0    
Stock repurchased and retired during period, value     $ 0        
Common stock              
Amount of shares repurchased             $ 100,000
Stock repurchased and retired during period, shares     0 986,928      
Shares repurchased average price per share       $ 15.12      
Stock repurchased and retired during period, value     $ 0 $ 14,900      
Additional Paid-In Capital              
Stock repurchased and retired during period, value     $ 393,829        
Additional Paid-In Capital | GSK              
Cost of treasury stock $ 393,800